Caminati, M. Et Al. 2024. Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group. Allergy: European Journal of Allergy and Clinical Immunology , vol.79, no.2 , 516-519.

Caminati, M., Fassio, A., Alberici, F., Baldini, C., Bello, F., Cameli, P., ... Conticini, E.(2024). Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group. Allergy: European Journal of Allergy and Clinical Immunology , vol.79, no.2, 516-519.

Caminati, Marco Et Al. "Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group," Allergy: European Journal of Allergy and Clinical Immunology , vol.79, no.2, 516-519, 2024

Caminati, Marco Et Al. "Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group." Allergy: European Journal of Allergy and Clinical Immunology , vol.79, no.2, pp.516-519, 2024

Caminati, M. Et Al. (2024) . "Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group." Allergy: European Journal of Allergy and Clinical Immunology , vol.79, no.2, pp.516-519.

@article{article, author={Marco Caminati Et Al. }, title={Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group}, journal={Allergy: European Journal of Allergy and Clinical Immunology}, year=2024, pages={516-519} }